Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Aug 28, 2026

PALI — Palisade Bio, Inc. Dilution Risk Tracker

Track PALI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PALI — Get alerts when the score changes →

As of August 28, 2026, Palisade Bio, Inc. (PALI) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Palisade Bio, Inc. has a market capitalization of $368.41M, 174.27M shares outstanding, 98 institutional holders tracked. Stored dilution-related fields include 644.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔄 Reverse Split model est. 15%
• 52-week low $0.53 has breached $1
🔔 Track PALI — Get forecast alerts →

Market Data

Market Cap$368.41M
Shares Outstanding174.27M
Float128.36M
Cash$130.17M
Debt$87.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 25.5% shares (2026Q1 vs prior)
98 institutional holders · 172.98M shares
#1 JANUS HENDERSON GROUP PLC 21.38M shares
#2 PERCEPTIVE ADVISORS LLC 17.86M shares
#3 B Group, Inc. 11.41M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest33.70M
Days to Cover14.6
% of Float26.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2014-12-31
8-K 8K EVENT 2026-04-02
4 INSIDER TRANSACTION 2026-02-13
4 INSIDER TRANSACTION 2026-02-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PALI Dilution Snapshot

Palisade Bio, Inc. (PALI) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PALI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PALI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PALI
PALI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.